Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Biotech
MapLight brightens SandboxAQ with CNS deal
The focus of the team-up is to find and develop drugs targeting a novel G protein-coupled receptor to address central nervous system diseases.
Darren Incorvaia
Dec 16, 2025 7:30am
Sanofi signs 2nd biotech deal of the day
Dec 15, 2025 5:50pm
Aviceda eye disease hopeful fails to top Astellas med in phase 2
Dec 15, 2025 2:14pm
Immunome's desmoid tumor treatment triumphs in phase 3
Dec 15, 2025 10:42am
How Zealand CSO aims to create a 'generational biotech leader'
Dec 12, 2025 1:00pm
Arcus halts Gilead-partnered TIGIT trials as it reworks R&D
Dec 12, 2025 10:00am
